Senna S 83059-0120
Generic: Docusate Sodium, Sennosides
Product NDC
83059-0120- Manufacturer
- Shield Pharmaceuticals Corp
- Dosage Form
- Capsule, Liquid Filled
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- December 5, 2025
- Listing Expires
- December 31, 2026
- Application
- M007
Active Ingredients
| Ingredient | Strength |
|---|---|
| Docusate Sodium | 50 mg/1 |
| Sennosides | 8.6 mg/1 |
Packaging Options(1)
60 CAPSULE, LIQUID FILLED in 1 BOTTLE (83059-0120-6)